Haploidentical Hematopoietic Stem Cell Transplantation: A Global Overview Comparing Asia, the European Union, and the United States

Biol Blood Marrow Transplant. 2016 Jan;22(1):23-6. doi: 10.1016/j.bbmt.2015.11.001. Epub 2015 Nov 10.


One of the major projects of the Worldwide Network for Blood and Marrow Transplantation (WBMT) is to promote hematopoietic stem cell transplantation (HSCT) in emerging countries in the world. For these countries, HLA haploidentical HSCT (haplo-HSCT) from family members is an attractive approach because of its cost effectiveness. To learn the current status, including recent trends, of haplo-HSCT, the WBMT invited speakers from major transplant centers in 3 regions (Asia, Europe, and North America) to present at its annual WBMT Joint Session. This article represents the direct reports from these 3 speakers in addition to introductions by 2 WBMT speakers who address data from the Global Transplant Activity survey. It must be emphasized, however, that certain promising results of haplo-HSCT presented in this article were obtained at well-experienced institutes.

Keywords: Beijing Protocol; Europe; Global Activity Survey; Haplo-HSCT; Haplo-transplantation; United States.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Allografts
  • Asia
  • European Union
  • Hematopoietic Stem Cell Transplantation*
  • Histocompatibility Testing*
  • Humans
  • United States